Patent · US Active

Transcription unit and use thereof in expression vectors

US9551009B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Laboratoire Francais du Fractionnement et des Biotechnologies · FR

Inventors

Alexandre Fontayne · La Madeleine, FR
Francois Coutard · Alès, FR

Key dates

Filing date	Oct 29, 2012
Grant date	Jan 24, 2017
Priority date	—
Expiry date	Oct 29, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/42
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A transcription unit constituted by a polynucleotide including the hCMVie virus enhancer, the enhancer having the nucleotide sequence SEQ ID NO: 1, or a nucleotide acid having at least 70% sequence identity with the sequence SEQ ID NO: 1 and essentially having transcription activation properties, and the promoter region of Cyclin-Dependent Kinase 9 (CDK9), the promoter region having the nucleotide sequence SEQ ID NO: 2, or a nucleotide acid having at least 70% sequence identity with the sequence SEQ ID NO: 2 and essentially having a promoter activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.